Global Scaffold Technology Industry: The Latest Research Report to Share Market Insights and Dynamics
The global scaffold technology market size is expected to reach USD 2.22 billion by 2028 according to a new study by Polaris Market Research. The report “Global Scaffold Technology Market Share, Size, Trends, Industry Analysis Report, By Type (Hydrogels {Wound Healing, 3D Bioprinting, Immunomodulation}, Polymeric Scaffolds, Micropatterned Surface Microplates, Nanofiber Based Scaffolds); By Application; By Disease Type; By End-Use; By Regions; Segment Forecast, 2021 – 2028” gives a detailed insight into current market dynamics and provides analysis on future market growth. The recent advancements in micro-molding, photo-lithography, and stereo-lithography also driving scaffolding technology. For instance, the innovations in injectable and microporous hydrogels also enabled organ on a chip technology to enhance in-vivo healing. Moreover, ongoing advancements in micro-fabrication technology are also projected to boost the market growth.
Get Sample Copy :https://www.polarismarketresearch.com/industry-analysis/scaffold-technology-market/request-for-sample
In 2020, the hydrogels market segment of scaffold technology industry had the largest revenue share. This high share is attributed to the excellent properties of hydrogels, such as controlled drug delivery, and ease of loading drugs. In current times, hydrogels have gained momentum and are regarded as a leading candidate in 3D cell cultures and tissue engineering. The nanofiber scaffolds segment is projected to show the fastest growth rate over the assessment period. Nanoscale fibrous structures with inter-connecting pores facilitate the formation of artificial tissues during the process of tissue engineering. Artificial tissues resemble natural ones, by providing an extracellular matrix of the living tissues. Market participants such as Merck KGaA, Molecular Matrix, Pelobiotech, Corning Incorporated, Avacta Life Sciences Limited, Vericel Corporation, Becton, Dickinson and Company, 3D Biotek LLC, Thermo Fisher Scientific, Xanofi, REPROCELL Inc., Matricel GmbH, Akron Biotech, Nanofiber Solutions, 4titude, 3D BioMatrix, NuVasive, Inc., Allergan, and Medtronic. are some of the key players operating in the global market for scaffold technology.
Players in the marketplace are collaborating with small players to stay competitive in the market for scaffold technology. For instance, in October 2019, Avacta Life Sciences collaboration agreement with ADC Therapeutics to develop Affimer drug conjugates, to use in biological scaffolds.